Total Payments
$89,175
2024 Payments
$11,486
Companies
8
Transactions
128
Medicare Patients
139
Medicare Billing
$12,664
Payment Breakdown by Category
Other$62,571 (70.2%)
Travel$21,222 (23.8%)
Consulting$3,075 (3.4%)
Food & Beverage$2,209 (2.5%)
Education$98.98 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62,571 | 24 | 70.2% |
| Travel and Lodging | $21,222 | 59 | 23.8% |
| Consulting Fee | $3,075 | 2 | 3.4% |
| Food and Beverage | $2,209 | 41 | 2.5% |
| Education | $98.98 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $85,529 | 107 | $0 (2024) |
| EMD Serono, Inc. | $3,075 | 2 | $0 (2020) |
| Janssen Products, LP | $312.12 | 4 | $0 (2019) |
| Gilead Sciences, Inc. | $132.52 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $47.16 | 5 | $0 (2019) |
| Roche Molecular Systems, Inc. | $38.97 | 1 | $0 (2017) |
| CMP Pharma, Inc. | $26.91 | 1 | $0 (2024) |
| Janssen Research & Development, LLC | $14.26 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,486 | 16 | Merck Sharp & Dohme LLC ($11,384) |
| 2023 | $5,419 | 7 | Merck Sharp & Dohme LLC ($5,403) |
| 2022 | $12,473 | 13 | Merck Sharp & Dohme LLC ($12,473) |
| 2021 | $2,102 | 3 | Merck Sharp & Dohme Corporation ($2,088) |
| 2020 | $31,742 | 37 | Merck Sharp & Dohme Corporation ($28,653) |
| 2019 | $25,641 | 45 | Merck Sharp & Dohme Corporation ($25,475) |
| 2018 | $273.18 | 6 | Janssen Products, LP ($191.94) |
| 2017 | $38.97 | 1 | Roche Molecular Systems, Inc. ($38.97) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,255.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $75.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $109.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $922.32 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,255.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $38.94 | General |
| 11/07/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.51 | General |
| 09/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.99 | General |
| 03/20/2024 | CMP Pharma, Inc. | Atorvaliq (Drug), CaroSpir, Liqrev | Food and Beverage | Cash or cash equivalent | $26.91 | General |
| Category: Cholesterol | ||||||
| 02/02/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,255.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/02/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $36.92 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/31/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $75.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/25/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/14/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,255.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/12/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/30/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | In-kind items and services | $823.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/30/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | In-kind items and services | $649.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/30/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | In-kind items and services | $398.80 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/30/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $125.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/23/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.99 | General |
| 12/23/2022 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,255.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/22/2022 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 53 | $39,114 | $4,156 |
| 2022 | 1 | 12 | 27 | $19,506 | $1,935 |
| 2021 | 2 | 23 | 40 | $15,830 | $2,210 |
| 2020 | 3 | 87 | 121 | $45,715 | $4,363 |
Total Patients
139
Total Services
241
Medicare Billing
$12,664
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 53 | $39,114 | $4,156 | 10.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 27 | $19,506 | $1,935 | 9.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 18 | $12,554 | $1,673 | 13.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 12 | 22 | $3,276 | $536.48 | 16.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 24 | 28 | $12,481 | $1,921 | 15.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 36 | 55 | $8,040 | $1,275 | 15.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 27 | 38 | $25,194 | $1,167 | 4.6% |
About Dr. Michael Harbour, MD
Dr. Michael Harbour, MD is a Infectious Disease healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013022169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Harbour, MD has received a total of $89,175 in payments from pharmaceutical and medical device companies, with $11,486 received in 2024. These payments were reported across 128 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($62,571).
As a Medicare-enrolled provider, Harbour has provided services to 139 Medicare beneficiaries, totaling 241 services with total Medicare billing of $12,664. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Stanford, CA
- Active Since 08/20/2006
- Last Updated 01/07/2010
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1013022169
Products in Payments
- PIFELTRO (Drug) $45,633
- DELSTRIGO (Drug) $35,554
- Serostim (Drug) $3,075
- PREZCOBIX (Drug) $201.32
- Symtuza (Drug) $157.96
- ISENTRESS (Drug) $52.45
- MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) $38.97
- Atorvaliq (Drug) $26.91
- PREZISTA (Drug) $14.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Stanford
Paul Eckburg, Md, MD
Infectious Disease — Payments: $100,040
Infectious Disease $100,040
Abraham Verghese, Md, MD
Infectious Disease — Payments: $96,844
Infectious Disease $96,844
Robert Shafer, M.d, M.D
Infectious Disease — Payments: $26,817
Infectious Disease $26,817
Hector Bonilla, Md, MD
Infectious Disease — Payments: $7,992
Infectious Disease $7,992
Dr. Susanna Tan, Md, MD
Infectious Disease — Payments: $7,180
Infectious Disease $7,180
Jose Montoya, Md, MD
Infectious Disease — Payments: $2,394
Infectious Disease $2,394